Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Koji Urasaki is active.

Publication


Featured researches published by Koji Urasaki.


Gastric Cancer | 2006

Intratumoral heterogeneity of MIB-1 labelling index in gastric gastrointestinal stromal tumor (GIST)

Hiroshi Yasui; Eiichi Konishi; Koji Urasaki; Satoru Yasukawa; Akio Yanagisawa

BackgroundThe MIB-1 labelling index (LI) is used as a prognostic indicator for gastrointestinal stromal tumors (GISTs). However, whether a biopsy-based LI represents the entire tumor is uncertain, because the LI is not always homogeneous. In this study, we examined the extent and characteristics of LI heterogeneity in gastric GISTs.MethodsWe analyzed ten c-kit-positive gastric GISTs with diameters exceeding 3 cm, of which six were multilobular and four were unilobular. For MIB-1-immunostained sections, continuous digital images were obtained through the maximum diameter of the lobules. We obtained LIs for images by carrying out computer-assisted image analysis, and calculated the means and standard deviations (SDs) of the LIs for the lobules. For each lobule, intralobular heterogeneity was evaluated on the basis of the SD. For multilobular tumors, interlobular heterogeneity was assessed on the basis of the mean LI difference between lobules.ResultsThe SDs, which ranged from 0.8% to 9.8%, indicated intralobular heterogeneity. Moreover, considerable interlobular heterogeneity was noted in five (83%) of the six multilobular GISTs, in which the maximum interlobular mean LI difference ranged from 9.6% to 27.2%. Notably, although the high maximum mean LI (14.1%–32.3%) showed that these five GISTs were high-grade tumors, they also contained at least one lobule showing a low-grade mean LI value (2.7%–5.1%).ConclusionGastric GISTs often show intralobular or interlobular MIB-1 LI heterogeneity. In multilobular GISTs, multiple biopsy samples may be required for the accurate evaluation of tumor grade.


Clinical Transplantation | 2006

Ten-year protocol biopsy findings of renal allografts in the calcineurin inhibitor era

Masahiko Okamoto; Kiyokazu Akioka; Hidetaka Ushigome; Atsushi Higuchi; Shuji Nobori; Shiro Ogino; Kenji Uryuhara; Satoshi Kaihara; Tsuguru Hatta; Koji Urasaki; Norio Yoshimura

Abstract:  Ten‐year protocol biopsies were performed in 16 patients treated with calcineurin inhibitor (CNI) continuously. All kidney grafts were functioning well at the time of biopsy with the mean serum creatinine level of 1.6 ± 0.8 mg/dL. The specimen of biopsy showed various degrees of tissue injury. According to the Banff grading, allograft glomerulopathy (cg) was observed in one case. Interstitial fibrosis (ci) and tubular atrophy (ct) were observed more frequently in 13 (81%) and 15 (93%) cases, respectively. Fibrous intimal thickening (cv) was seen in one (7%) case. Arteriolar hyaline thickening (ah) was seen in 14 (87%) cases. These findings were associated with chronic rejection in one case, recurrence of original disease in four (25%) cases, toxicity of CNI in 14 (87%) cases. Longer follow‐up studies are needed to confirm whether CNI should be continued or not in the long‐term period following kidney transplantation for better graft survival.


Clinical Transplantation | 2009

Histopathologic evaluation of living kidney donor candidates by pre-operative kidney biopsy

Masahiko Okamoto; K. Sakai; T. Suzuki; Shuji Nobori; Hidetaka Ushigome; Seisuke Sakamoto; Koji Urasaki; Yasukiyo Mori; Kiyokazu Akioka; Shoichiro Daimon; Norio Yoshimura

Abstract:  A lack of deceased kidney donors in Japan has led to dependence on living donors in as many as 80% of cases. At the same time, indications for living‐donor kidney donation have been expanding in terms of donor medical status as well as HLA matching and ABO compatibility, thus emphasizing the donor shortage. To facilitate final medical decision‐making for living kidney donation, we attempted kidney biopsy in six donor candidates who had problems such as mild diabetes and slight proteinuria. The biopsy specimens showed various degrees of tissue injury ranging from partial glomerular sclerosis to arteriole hyalinization. On the basis of the biopsy findings, kidney donation was subsequently performed in three of the six cases with full informed consent, and not done in the remaining three cases. Longer‐term studies will be needed to clarify the outcome in both the donors and recipients in these cases.


Clinical Transplantation | 2011

Overlapped glomerular lesions of chronic rejection and recurrent lupus nephritis in transplanted kidney: a case report

Naoko Masuzawa; Koji Urasaki; Masahiko Okamoto; Shuji Nobori; Hidetaka Ushigome; Norio Yoshimura; Akio Yanagisawa

Masuzawa N, Urasaki K, Okamoto M, Nobori S, Ushigome H, Yoshimura N, Yanagisawa A. Overlapped glomerular lesions of chronic rejection and recurrent lupus nephritis in transplanted kidney: a case report.
Clin Transplant 2011: 25 (Suppl. 23): 49–52.
© 2011 John Wiley & Sons A/S.


Clinical Transplantation | 2009

A case of living-related renal transplant from the donor with membranous nephropathy.

Kiyokazu Akioka; Masahiko Okamoto; Hidetaka Ushigome; Shuji Nobori; T. Suzuki; K. Sakai; Seisuke Sakamoto; Koji Urasaki; Akio Yanagisawa; Atsushi Fukatsu; Norio Yoshimura

Abstract:  Introduction:  When a patient who had renal replacement therapy becomes older, an elder donor candidate may be considered as a potential donor for living‐related transplantation. Elder donor candidate might have pre‐existing disease including mild renal dysfunction, such as proteinuria. Marginally appropriate donors might be considered for renal graft because of the shortage of donors. A successful outcome after kidney transplantation from a living‐related donor diagnosed as membranous nephropathy is reported.


Clinical Transplantation | 2007

A rare case of vascular rejection in a renal transplant recipient with nephrotic range proteinuria

Kiyokazu Akioka; Masahiko Okamoto; Hidetaka Ushigome; Shuji Nobori; Koichi Kozaki; Satoshi Kaihara; Koji Urasaki; Akio Yanagisawa; Kunio Morozumi; Norio Yoshimura

Abstract:  In the post‐cyclosporine A era, it has been reported that acute rejection after kidney transplantation is commonly revealed as an asymptomatic increase in the serum creatinine level. Nephrotic range proteinuria is observed in patients with recurrent or de novo glomerulonephritis, or with chronic transplant nephropathy and glomerulopathy in the late phase. Acute rejection occurring with nephrotic range proteinuria without a rise of serum creatinine has been rarely reported. Here, we report a rare case of vascular rejection in a renal transplant recipient with nephrotic range proteinuria. A 34‐yr‐old male renal transplant recipient presented with acute vascular rejection and early‐onset nephrotic syndrome. Severe nephrotic range proteinuria was detected with a minimally elevated level of serum creatinine. Biopsy showed severe glomerulitis and vasculitis, which was relieved by conversion of the immunosupressant regimen. Severe proteinuria was a sign of acute vascular rejection with severe glomerulitis and vasculitis. Careful observation to ensure maintenance of immunosuppression is necessary in such cases.


Clinical Transplantation | 2010

Analysis of preexisting baseline kidney lesions revealed by biopsy in living kidney donors: relationship with clinical parameters at the time of donation

Masahiko Okamoto; Katsuhiro Koshino; Shuji Nobori; Hidetaka Ushigome; Hideaki Okajima; Koji Urasaki; Norio Yoshimura

Okamoto M, Koshino K, Nobori S, Ushigome H, Okajima H, Urasaki K, Yoshimura N. Analysis of preexisting baseline kidney lesions revealed by biopsy in living kidney donors: relationship with clinical parameters at the time of donation.
Clin Transplant 2010: 24 (Suppl. 22): 27–30.


Journal of Gastroenterology and Hepatology | 2005

SYNCHRONOUSLY RESECTED DOUBLE PRIMARY HEPATIC CANCER, HEPATOCELLULAR CARCINOMA AND CHOLANGIOCARCINOMA

Nobuaki Fuji; Hiroki Taniguchi; Hisashi Amaike; Katsuhiko Oka; Yasunari Tsuchihashi; Koji Urasaki; Kazuyo Naito


Breast Cancer | 2005

A case of non-metastatic giant mucinous carcinoma of the breast

Yuki Mizuta; Naruhiko Mizuta; Koichi Sakaguchi; Yasushi Hachimine; Kiyoshi Sawai; Koji Urasaki; Satoru Yasukawa; Hiroo Nakajima


Hepato-gastroenterology | 2003

Resection of a pelvic schwannoma with partial removal of the sacral nerve root.

Eigo Otsuji; Akeo Hagiwara; Atsushi Toma; Koji Urasaki; Yasunari Tsuchihashi; Hisakazu Yamagishi

Collaboration


Dive into the Koji Urasaki's collaboration.

Top Co-Authors

Avatar

Hidetaka Ushigome

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Masahiko Okamoto

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Norio Yoshimura

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Shuji Nobori

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Akio Yanagisawa

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Kiyokazu Akioka

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Satoru Yasukawa

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hiroo Nakajima

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

K. Sakai

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Kiyoshi Sawai

Kyoto Prefectural University of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge